Advance in Plasma AD Core Biomarker Development: Current Findings From Immunomagnetic Reduction-Based SQUID Technology
Neurology and Therapy - United States
doi 10.1007/s40120-019-00167-2
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2019
Authors
Publisher
Springer Science and Business Media LLC